Fund overview & performance

Asset class

Based on three-year return


Annualized returns

Between % and %

 


Fund management

Series

Clear all filters

Canada Life Global All Cap Equity Fund F

September 30, 2025

The fund seeks long-term capital growth by investing primarily in equities of companies located anywhere in the world, either directly or through other investment funds.

Is this fund right for you?

  • Investors who are looking for a global equity fund to hold as part of their portfolio
  • Want a medium-to long-term investment
  • Can handle the volatility of stockmarkets

Risk Rating

Risk Rating: Moderate

How is the fund invested? (as of July 31, 2025)

Asset allocation (%)

Name Percent
US Equity 56.3
International Equity 43.1
Cash and Equivalents 0.5
Other 0.1

Geographic allocation (%)

Name Percent
United States 56.3
Ireland 11.3
France 6.9
Taiwan 3.9
Switzerland 3.1
Denmark 2.9
United Kingdom 2.8
Germany 2.0
China 1.7
Other 9.1

Sector allocation (%)

Name Percent
Technology 26.8
Financial Services 18.0
Consumer Goods 10.6
Healthcare 10.2
Industrial Goods 9.2
Consumer Services 9.1
Industrial Services 4.3
Energy 4.0
Utilities 2.8
Other 5.0

Growth of $10,000 (since inception)

Data not available based on date of inception

Fund details (as of July 31, 2025)

Top holdings %
Oracle Corp 4.7
Microsoft Corp 4.7
Alphabet Inc Cl A 4.2
Taiwan Semiconductor Manufactrg Co Ltd - ADR 3.9
Booking Holdings Inc 3.9
Berkshire Hathaway Inc Cl B 3.6
Meta Platforms Inc Cl A 2.8
Nike Inc Cl B 2.5
Marsh & McLennan Cos Inc 2.4
Ryanair Holdings PLC - ADR 2.4
Total allocation in top holdings 35.1
Portfolio characteristics
Standard deviation 10.6%
Dividend yield 1.7%
Yield to maturity -
Duration (years) -
Coupon -
Average credit rating Not rated
Average market cap (million) $750,643.4

Understanding returns

Annual compound returns (%)

1 MO 3 MO YTD 1 YR
{{snapShot.Return1Mth|customNumber:1}}{{snapShot.Return3Mth|customNumber:1}}{{snapShot.ReturnYTD|customNumber:1}}{{snapShot.Return1Yr|customNumber:1}}
3 YR 5 YR 10 YR INCEPTION
{{snapShot.Return3Yr|customNumber:1}}{{snapShot.Return5Yr|customNumber:1}}{{snapShot.Return10Yr|customNumber:1}}{{snapShot.ReturnInception|customNumber:1}}

Calendar year returns (%)

2024 2023 2022 2021
{{snapShot.Return1YrCalendar|customNumber:1}}{{snapShot.Return2YrCalendar|customNumber:1}}{{snapShot.Return3YrCalendar|customNumber:1}}{{snapShot.Return4YrCalendar|customNumber:1}}
2020 2019 2018 2017
{{snapShot.Return5YrCalendar|customNumber:1}}{{snapShot.Return6YrCalendar|customNumber:1}}{{snapShot.Return7YrCalendar|customNumber:1}}{{snapShot.Return8YrCalendar|customNumber:1}}

Range of returns over five years (September 1, 2018 - September 30, 2025)

Best return Best period end date Worst return
Worst period end date
13.9% Sept. 2025 4.3% Sept. 2023
Average return % of periods with positive returns Number of positive periods Number of negative periods
9.0% 100.0% 26 0

Q2 2025 Fund Commentary

Market commentary

Global equities declined early in the second quarter of 2025 because of U.S. tariff announcements. However, they later recovered as the U.S. administration paused tariffs. Over the entire quarter, global equities rose 5.7% in Canadian-dollar terms and 11.5% in U.S.-dollar terms.

The U.S. dollar weakened against most other major currencies. The U.S. passed a budget bill that was expected to significantly add to the national debt, which could lead to higher borrowing costs.

Performance

The Fund’s relative exposure to Oracle Corp., Microsoft Corp. and Taiwan Semiconductor Manufacturing Co. Ltd. had the most positive impact on performance. Relative exposure to UnitedHealth Group Inc., Berkshire Hathaway Inc. and Marsh & McLennan Cos. Inc. was negative for performance.

At the sector level, stock selection in information technology and industrials was positive for performance. Underweight exposure to information technology and overweight exposure to health care had a negative impact on performance.

Currency effects had a positive impact on performance.

Portfolio activity

The sub-advisor sold Johnson & Johnson, HF Sinclair Corp. and Edenred SE.

Outlook

The sub-advisor favours attractively valued global companies whose performance is not driven by macroeconomic events.

Irish Life Investment Managers Limited

Contact information

Toll free: 1-844-730-1633

{{ snapShot.FundName.replace("<em>", "").replace("</em>", "") }}
No matching records found.

Summary

For the period {{NAVPSPerformanceSummary.StartDate}} through {{NAVPSPerformanceSummary.EndDate}} with $10,000 CAD investment

Total returns performance

{{NAVPSPerformanceSummary.Growth | customPercentage}}

Last price

{{NAVPSPerformanceSummary.NAVPS | customCurrency}} CAD

as of market close {{NAVPSPerformanceSummary.NAVPSDate}}

Value of $10,000 investment

{{NAVPSPerformanceSummary.GrowthOfTenThousand | customCurrency}} CAD

Export to: